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Nanofibers have shown promising results as an excellent drug delivery platform 
and a wound healing medium due to their fibrous morphology and high porosity. They are 
also a highly versatile nanosystem with customizable material composition and surface 
structure. Recent emergence of the cell membrane cloaking technology and its 
  
ix 
 
detoxification capability enabled a new way of nanofiber functionalization. The endotoxin 
and cytokine neutralizing properties of mouse J774 macrophage cell membrane coated 
nanoparticles (MϕNP) have previously been reported, but the nature of free nanoparticles 
prohibits local cytokine neutralization. Herein, we introduce a triple-action nanofiber-
nanoparticle hybrid system that functions both as a drug delivery and a MϕNP retention 
platform. This project explored attaching MϕNP onto dual-drug loaded polycaprolactone 
(PCL) nanofiber surface. Our final nanoparticle-nanofiber hybrid system attenuates 
inflammation in three directions: curcumin reduces inflammation through modulating 
cytokine transcription; ciprofloxacin provides powerful anti-microbial effects; the attached 
MϕNPs show improved cytokine neutralization. The hybrid system serves as a new way 
to integrate traditional drug-delivery nano-platforms with the innovative biomimetic 
membrane toxin-neutralizing nanoparticles.
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Introduction 
Inflammation is an important process from the immune system when encountering 
external stimuli. During wound healing, inflammation helps recruit immune cells to the 
local wound site. The immune cells are responsible for secreting growth factors that 
promote cell proliferation and wound closure. However, in some cases, inflammation can 
also negatively impact wound healing. In the presence of endotoxin or bacteria, 
inflammation can go into a chronic state, which degrades growth factors. Hence, 
inflammation needs to be controlled in many cases. Efficient delivery of anti-inflammatory 
drugs has been studied extensively in research. The structure and the biocompatibility of 
the delivery medium is the key to effective drug delivery.  
This Master thesis project explores the possibilities of using nanofibers as a drug 
delivery platform and a membrane NP retention scaffold to provide cytokine and endotoxin 
neutralization, anti-inflammatory and antibacterial activities, as well as possible wound 
healing efficacies. The project creates a nanofiber/nanoparticle hybrid system, which 
consists of multiple components that target different problems during wound healing. This 
system achieves the goals by attaching mouse J774 macrophage cell membrane coated 
PLGA nanoparticles (Macrophage NP) onto PCL nanofibers while simultaneously load 
curcumin and ciprofloxacin into the fibers. Macrophage NPs are responsible for cytokine 
and endotoxin neutralization as previously reported; curcumin provides anti-inflammatory 
properties; and ciprofloxacin, a common antibiotic, acts as a powerful anti-bacterial agent. 
Various specific experiments were designed to verify the role of each component. 
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Background 
Nanofibers 
 
The advancement in nanofabrication technologies allows production of polymer 
fibers in the submicron scale. Common fiber manufacturing techniques such as melt 
processing and electrospinning are able to produce polymer fibers ranging from a few 
microns to several nanometers in diameter. Extensive applications and intensive research 
on those thin materials have granted the fibers a unique name—nanofibers. Nanofibers are 
defined by any fibrous material with diameter in the nanoscale (typically less than 100 nm) 
(1). The term has later extended to also define submicron fibers that are more than 100 nm 
due to their similar physical properties with the thinner counterpart as well as their wide 
adoption in research and industry (1). Because of their high surface area to weight ratio, 
easy control of their functionality, high permeability and ease of production, nanofibers 
have been widely used in medical, energy, and many other fields in the industry (2).  
Electrospinning is an extremely versatile and simplistic method to fabricate 
nanofibers using a broad spectrum of materials, including organic, inorganic, metals and 
metal oxides. Polymer is normally dissolved in organic solvents or melted into liquid state 
before loaded into the spinning equipment and used as the raw fiber material. A typical 
experimental setup consists of four main components: a syringe filled with dissolved or 
molten polymer solution, a syringe pump to ensure consistent delivery of the polymer 
solution, a conductive collector at a desired distance, and a high voltage power supply to 
apply an electric field between the metal tip and the collector 3 (Figure 1). The voltage for 
the electric field is generally high, (between 10-50 kV) (3). The principle of the 
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electrospinning technology is rather simple. Since the electrodes are applied between the 
blunted syringe needle and the collected, polymer solution coming out the tip becomes 
highly charged.  
Although the components and operations of electrospinning are relatively simple, 
the mechanism of fiber formation is complicated and not fully understood. Two models 
have been developed through experimental observations are Taylor Cone and the jet flow 
instability (3). The two theories describe the spinning mechanism at the metal tip and 
during the flight towards collector, respectively. Other than the inherent surface tension on 
the face of the droplet, two major repulsive electrostatic forces will exert on the fluid 
droplet: surface charge electrostatic repulsion and Coulombic force from the electric field 
(4). Because of the electric field and the  
resulting forces, the polymer droplet at the metal tip deforms into a conical shape, which 
has widely been referred to as the Taylor Cone (5). When the voltage increases, the 
repulsive forces will overpower the surface tension, a jet of polymer solution will burst out 
of the Taylor Cone and be pulled towards the fiber collector, which is served as the counter 
electrode (3). The jet will elongate and become thinner under electric field’s strong driving 
force, and the organic solvent will evaporate during the process, leaving the dry stretched 
solid polymer on the metal collector. The jet flow towards the collector resembles spiraling 
motion rather than a straight path (3). In Bending instability of electrically charged liquid 
jets of polymer solutions in electrospinning by Reneker et al., the path is described to have 
3 main stages, which are quoted below: 
4 
 
 
 
“Step 1 A smooth segment that was straight or slightly curved suddenly developed an array 
of bends.  
“Step 2 The segment of the jet in each bend elongated and the array of bends became a 
series of spiraling loops with growing diameters.  
“Step 3 As the perimeter of the loops increased, the cross-sectional diameter of the jet 
forming the loop grew smaller; the conditions for step 1 were established on a smaller scale, 
and the next cycle of bending instability began.” (6) 
The jet will keep spiraling towards the collector while forming new instabilities within 
itself (6). The overall flight path resembles a fractal pattern, which is determined by any 
pattern that defines its shape at any scale. Because of the flight path’s instability and its 
complexity to predict using mathematical models, the fiber thickness on the metal collector 
varies almost randomly rather than a straightforward radial pattern.  
Though operations of electrospinning are simple, and the learning periods for most 
researchers are brief, different combinations of parameters need to be explored so that the 
consistency of fiber formation is a guarantee. The different parameters and their impacts 
on fiber size, morphology and other overall quality have been extensively documented in 
various literature. In the article Effect of Electrospinning parameters on the Nanofiber 
Diameter and Length, by V. Beachley et al., the authors investigated the impacts of feed 
rate, polymer concentration, voltage, addition of salt, and plate size. Different parameters 
were experimentally explored, and the fibers’ lengths and diameter information was 
collected and analyzed through Holm’s test (7). Polymer solution flow rate seems to have 
minimal effects on the fiber quality. Although sufficient rate of feed is need for Taylor 
Cone formation, excess feed will merely accumulate on the needle tip or deposit on the 
collector in the forms of clumps or droplets (7). Solution concentration affects fiber 
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diameter and length with noticeable influences from small changes in concentration (7). 
Higher voltage also seemly has a positive impact on uniformity, but the system will 
produce fibers in short lengths (7). Collect plate size also changes the size of the ground 
terminal, therefore, changing product’s diameter and length (7).  
Enough distance allows the polymer solution to be sufficiently dried and stretched 
before reaching the grounded collector (8). Shorter distance also provides stronger electric 
field, which is also known to produce inconsistent results with increasing field strength (3), 
(7). Excessive distance makes sustaining an adequate and consistent electric field harder. 
It also allows more travel distance for the solution droplet, during which numerous flow 
instability can develop and cause inconsistent fiber thickness as well as possible excess 
beading. Bioresorbable Nanofiber-Based Systems for Wound Healing and Drug Delivery: 
Optimization of Fabrication Parameters by Katti et al. looks more in depth into the effect. 
It argued that it is rather the electric field strength density, represented by field strength in 
kilovolts per unit distance between the collector and the tip, that is important for product 
morphology change (9). A lower voltage or a longer collector distance can create weak 
electric field for polymer elongation. It is a more reasonable approach because the field 
strength is usually defined by both parameters. In their experiment, electric fields ranging 
from 0.5 to 1.5 kV/cm are tested for electrospinning (9). Their experimental data are 
presented in Figure 3. Through the results, they concluded that weak electric field can 
create thicker or even micron-sized fibers, and while higher voltage is generally favorable, 
excessively strong electric field can also have an adverse effect on fiber diameter (9). 
Therefore, it is important to experimentally explore the optimal electric field strength for 
each polymer and solvent combination.  
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Other environmental factors that are harder to control, such as humidity and 
temperature also have different degrees of effects on overall product outcome. 
Because of its ease of production and overall versatility, nanofibers have been used 
in numerous applications, especially in medical applications and research. Drug and gene 
delivery with nanofibers has shown great promises due to the fibers convenience to include 
additional  
formulations. Drugs can be simply mixed into the polymer solution and spun just as a part 
of fiber materials. The release mechanism can also be tuned from different geometrical 
designs to achieve release profiles from rapid to delayed (10). Hollow and core-shell fiber 
configurations can also be achieved by embedding a capillary inside the spinneret needle 
and feeding two immiscible solvents into the electrical field (11). Core-shell configuration 
specifically avoids the initial fast release of the loaded products and allows drug loading in 
the inner core of the product, thus permitting better tuning of the release profile through 
adjusting the thicknesses of the core and the shell.  
When the formulation is chemically stable under electrospinning conditions, it can 
be embedded within the nanofibers through simple mixing with the spinning solution, the 
core-shell nanofibers can also be used to control the drug release profile. However, for 
unstable formulations, surface modifications are often done to the nanofibers to allow 
desired functionality after the nanofibers are already produced. In a review article by Hyuk 
Sang Yoo et al., three other common modification methods are introduced. Certain 
formulations and drugs cannot be blended into polymer solution for various reasons. Some 
hydrophilic drugs, such as chitosan, can be difficult to dissolve in polymer solvents such 
as chloroform. Furthermore, formulations containing nucleic acids or proteins can be 
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degraded when exposed to organic solvents, as well as, strong electric fields (12). The three 
common physical surface modifications are physical adsorption, surface nanoparticle 
adsorption, and layer-by-layer (LbL) layout (12). The illustration of the three modifications 
are shown in Figure 2 (12). Surface nanoparticle absorption allows nanoparticle integration 
into the fiber mesh. The particles can contribute a whole new spectrum of functionalities 
to the system, including secondary drug delivery, bactericidal properties and toxin 
neutralization. Chul Ho Park et al. combines the traditional electrospinning and 
electrospray methods and attaches nanoparticles onto the fiber surface through opposite 
electric charge attraction (13). Nanoparticles are sprayed through a separate nozzle charged 
with the opposite potential as the fiber electrospinning nozzle (13). In their experiment, 
NaF nanospheres are deposited onto the PMMA nanofiber surface (13). This modification 
adds another function to the nanofibers in dental applications as Fluorine can offer various 
dental benefits including resisting dental caries and demineralization (13), (14). Rujitanaroj 
et al. combines Ag nanoparticles with electrospun gelatin nanofibers (15). While gelatin 
nanofibers promote tissue growth, the silver nanoparticles give them an extra boost with 
offering antibacterial abilities (15).  
Drug delivery applications with nanofibers have long been studied in the research 
and applied in medical fields. Wound healing capabilities of the nanofibers have also 
acquired increasing interests in research. Nanofibers not only promote tissue regrowth by 
mimicking the extracellular matrix but also allow loading of formulations such as curcumin 
and growth factors to further promote wound closure. Wound healing mechanisms and 
fiber assisted wound closure will be covered in greater details in the next chapter.  
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Figure 1 (3) Schematic illustration of a typical electrospinning setup 
 
Figure 2 (12) the nanofiber fiber surface can be modified in several ways including simple 
drug adsorption, nanoparticle adsorption, and multilayer assembly 
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Figure 3 (9) The effect of voltage strength on resulting fiber diameter.  
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Curcumin 
 
Derived from turmeric, curcumin has long been acknowledged as a healthful 
chemical due to its healing ability for the wound. It is derived from an Indian spice called 
Curcuma Longa Linn and used originally as a yellow food dye and food preservative (1). 
Curcumin was first purified from the spice in 1815 and its structure thoroughly studied by 
Kazimierz Kostanecki, J. Milobedzka and Kiktor Lampe in 1910 (2). The compound is 
fluorescent in acetonitrile λ	
 = 524 nm, ethanol (λ	
 = 549 nm), or micellar solution 
(λ	
 = 557 nm) (3). It is soluble in most organic solvents and insoluble in water and 
many other common solvents such as ethanol (1). Curcumin is insoluble in water in acidic 
or neutral environments (< 0.1 mg/ml) but is more soluble in alkaline environments (3 
mg/ml) (4).  
Before it moved under the spotlight in research field, different turmeric curcumin 
supplements have already emerged in the consumer market and becoming more popular 
throughout the years because of its proclaimed health benefits in various traditions (5). In 
fact, in Indian Ayurvedic medicine turmeric has been used to treat all ranges of conditions 
and illnesses including wound, skin problems, and liver problems without any known side 
effects since 1900 BC (6), (7). Not only its benefits have been recognized through 
traditional practice but also scientific research has proven that curcumin has ability to 
interact with intracellular proteins and enzymes and influence signaling pathways (8). 
Curcumin targets multiple upstream pathways, many of which are unknown, to induce cell 
proliferation, reduce inflammation, and stop tumor growth.    
12 
 
 
 
   Curcumin acts on multiple pathways to reduce the cells response to various pro-
inflammatory cytokines. Many intracellular proteins can be mediated by curcumin at 
multitudinous levels and pathways. Nuclear factor κB (NF-κB), for example, is a major 
transcription factor protein responsible for the transcription of numerous pro-inflammatory 
cytokines, including tumor necrosis factor alpha (TNF-α), and interleukin-6 (IL-6), upon 
endotoxin or cytokine stimulation.  
   NF-κB is a heterodimer consisting of two subunits: RelA (p65) and NF-κB1 (p50) 
(9). With no stimulation, NF-κB is inhibited by the endogenous inhibitor IκB (9). 
Cytokines and endotoxins bind to their corresponding receptors on the cell membrane (for 
instance, TNF-α binds to TNFR receptor, and lipopolysaccharide (LPS) binds to Toll-like 
receptor4 (TLR4)) and undergo complex but similar pathways to activate NF-κB as the 
result. In the case of LPS/TLR4 interaction, it involves complicated interactions among 
membrane proteins such as TLR4, CD14, MD-2, and LPS binding protein (LBP) (10). In 
fact, LPS itself does not directly bind to the TLR4 receptor, according to Lu et al (10). LPS 
will bind directly to MD-2, a protein that attached non-covalently to TLR4 (10). The 
interaction can still happen without the presence of TLR4 in vitro, although TLR4 does 
increase the affinity of LPS to MD-2 (10). LBP, which is also known as the LPS shuttle 
protein, mediates the interaction of LPS with CD-14, which later helps transferring LPS to 
the TLR4/MD-2 receptor (10). Cytokines such as TNF-α and IL-6 undergo similar 
recognition processes though they involve different cytokine specific receptors. Upon 
accepting cytokine or endotoxin signals, protein NF-κB inhibiting kinase (NIK) is activated 
(9). NIK activates the IκB kinase complex (IKK), which is responsible for IκB 
phosporylation and ubiquination (9). IKK phosphorylates IκBα and IκBβ at serine residues 
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32 and 36, and residues 19 and 23, respectively (11).  Then, IκB becomes phosphorylated 
and undergoes proteasome-mediated degradation through activation of 26S proteolytic 
complex (9), (12). Free NF-κB is therefore released to enable cytokine transcription (12). 
A detailed graphical demonstration of the activation in the cases of TNF-α and LPS 
stimulation is shown in Figure 4 (13). 
   Curcumin has been shown to reduce RelA (p65) nuclear translocation, IκBα 
degradation, and IκB serine 32 phosphorylation, according to Jobin et al (9). They 
conducted experiments to show decreased p65 translocation under IL-1β after curcumin 
treatment (9). In their study, HT-29 cells were first pre-treated with different doses of 
curcumin then stimulated with IL-1β (9). Nuclear extracts were taken from the cells and 
stained for p65 (9). Results are attached in Figure 5 (9). P65 translocation was not observed 
on the control cells (no IL-1β), but it was present upon cytokine stimulation (9). 75μM 
curcumin was enough to reduce p65 levels dramatically, as shown in the qualitative 
staining (9). A higher dose of curcumin of 150 μM decreased the levels even more (9). 
Meanwhile, p50, the other NF-κB subunit, remained unaffected (9). Jobin et al concludes 
that p65 is the major component inhibited by curcumin (9). The same can be seen in Figure 
5 B. Caco-2 cells were treated with curcumin then inflammation induced with IL-1β (9). 
RelA (p65) is stained with anti-RelA primary antibody to visualize its translocation (9). An 
increased optical signal from p65 is observed when the cells are treated with IL-1β, yet the 
signals are not seen in either the cytokine-negative control group or the group treated with 
both IL-1β and 100 μM curcumin (9).  
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   The group also conducted experiments to show curcumin can not only affect NF-
κB activation through inactivating p65 translocation, but also modulates upstream 
pathways to inhibit its activation (9). Mitogen-activated protein kinase kinase kinase 1 
(MEKK-1), according to Jobin et al, is a protein kinase that can activate NF-κB and many 
other separate signaling pathways, including the c-jun N-terminal kinase (JNK), as the 
result of a cytokine stimulation (TNF-α and IL-1) (9). JNK belongs to a pathway that is 
separate from the NF-κB activation with identical activation origin (MEKK-1) (9). 
Curcumin's inhibitory effects were demonstrated by measuring the luciferase activity after 
being incubated with MEKK-1 and curcumin (9). NF-κB inhibitor MG-132 was also used 
to demonstrate the effect of NF-κB inhibition on luciferase activities (9). Three groups of 
HT-29 cells were incubated with IL-8 luciferase reporter gene (IL-8 LUC) vectors, MEKK-
1 and IL-8 LUC vectors, and MEKK-1, IL-8 LUC, and MG-132 expression vectors, 
respectively (9). Their data are included as Figure 6 (9). As expected MG-132, which 
expects to inhibit NF-κB expression, reduced the IL-8 luciferase activity (Figure 6A) (9). 
Curcumin targets MEKK-1 signaling pathway from cytokines and achieved a similar effect 
as the NF-κB inhibitor (Figure 6C) (9). The data are not surprising as curcumin is known 
to reduce NF-κB DNA binding, but what was interesting was that it also seems to affect 
another side pathway resulted from cytokine/MEKK-1 stimulation (9). Instead of IL-8 
LUC, the group transfected TPA-responsive element reporter gene (TRE-LUC) into HT-
29 cells (9). TRE-LUC works by detecting the binding activity of the binding site 12-O-
Tetradecanoylphorbol-13-acetate (TPA) on Activator Protein-1 (AP-1) (14). AP-1 is 
related to c-jun and c-fos from a MEKK-1 side pathway separate from NF-κB activation 
(15). Upon cytokine activation, TRE-LUC detected activity from the TPA-responsive 
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element (9). The activity cannot be inhibited by MG-132 due to the fact that it is from a 
separate pathway (Figure 6B) (9). However, curcumin treatment is able to also reduce the 
luciferase signal (Figure 6D) (9). From their data, the group was able to conclude that in 
addition to the inhibition of specific elements, like IκBα and p65 in the NF-κB pathway, it 
also targets upper stream signaling pathways before the signals from MEKK-1 start 
branching off into multiple pathways (9).  
   Not only does curcumin inhibit pro-inflammatory cytokine production through 
affecting the corresponding signaling pathways in multiple levels, including modulating 
specific cytokine transcribing proteins, it also has been found to boost wound healing 
efficacy in vivo.  
   Aside from its well-proven anti-inflammatory efficacy, which promotes wound 
healing, curcumin helps wound closure at other stages as well. According to Akbik et al., 
fibroblast granulation tissue formation is essential for effective wound healing, as some 
chronic wound failed to heal due to inhibitions of fibroblast migration and granulation (16). 
Mohanty et al. developed a type of curcumin loaded Oleic Acid Based Polymeric (COP) 
bandage to accelerate wound healing (17). Although the material itself is expected to 
provide some wound healing benefits, curcumin further enhances the efficacy of the whole 
system (17). In their in vivo study, their bare polymeric bandage without curcumin showed 
moderate wound healing efficacy compared to the control group (17). However, when the 
material is loaded with curcumin, wound closure was accelerated even further, with the 
wound closing almost completely on the Day 10 (17). Furthermore, myofibroblast staining 
using smooth muscle α actin (SMA) also showed increased myofibroblast distribution on 
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the wound of curcumin treated group, superseding both the control and blank bandage 
groups (17). The result suggests that curcumin enhances wound closure by promoting 
fibroblasts/myofibroblasts proliferation at the wound site.  
   In addition, curcumin has been shown to improve collage deposition as well, 
according to Akbik et al. (16). Described in the wound healing section, collage deposition 
is the last extracellular matrix formation during wound healing. Curcumin is able to help 
produce thicker and compact collage extracellular matrix, according to Dai et al (18). From 
their Masson's Trichrome staining for collagen, their group of mice treated with curcumin 
loaded chitosan alginate sponge was able to produce well-aligned collagen matrix, and it 
is thicker than both the control group (gauze only), and the bare alginate sponge groups 
(18).   
   Cell apoptosis is also important because the wound needs to be rid of extra 
inflammatory cells in order to progress from the inflammatory phase to proliferation phase 
(16). Using agarose gel electrophoresis, Mohanty et al. detected higher levels of apoptotic 
cells in their COP and bare bandage groups compared to control on Day 4, with COP 
treated mice presenting slightly higher apoptotic levels (17). On Day 10, COP group had 
decreased levels of apoptosis, indicating the wound moving out of the inflammation stage, 
whereas the control and bare bandage groups showed higher levels apoptosis (17).   
   Even though curcumin promises impressive in vitro and in vivo efficacy, its 
physical properties can dramatically limit the drugs in vivo bioavailability. Other sources 
have suggested that the drug degrades quickly under neutral or alkaline conditions but is 
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stable in pH < 6.0 (4). Thus, its poor solubility in stable pH and many other properties limit 
curcumin's bioavailability, and it's mostly widely applied in tubular lower GI tract (4).  
   A chemical compound's Bioavailability can be determined by its many properties 
and interactions with a physiological system. For example, a drug's poor bioavailability 
can be caused by its low rates of uptake and metabolism, fast clearance from the body, and 
low intrinsic activity etc. (6) In the case of curcumin, problems such as short half-life, fast 
metabolism, low serum levels and tissue distribution negatively impacted curcumin's 
bioavailability (6). According to Anand et al., curcumin's bioavailability is limited through 
four major aspects: low serum concentration, poor tissue distribution, fast clearance, and 
short half-life (6).  
   Low curcumin serum level was observed by Wahlstrom et al. through monitoring 
blood plasma curcumin levels after orally administering 1g/kg of curcumin to rats (19). 
Negligible amount of curcumin was detected in the plasma (19). When the dosage is 
increased to 2g/kg to rats, curcumin serum concentration is detected at 1.35 μg/ml after 
0.83h (20). However, when humans are exposed to the same dosage the serum level can be 
low or undetectable (20). Curcumin serum levels can be boosted by injecting the drug 
intravenously (i.v.). Same dosage of 10 mg/kg to rats showed a six-fold increase when 
introduced i.v. versus orally (21).  
   Low serum concentration naturally leads to low tissue distribution. After oral 
administration of curcumin, 90% of curcumin stayed in the stomach after 30 mins, and 1% 
left after 24 hours, according to Ravindranath et al (6), (22). Through measuring tritium-
labeled curcumin levels in the tissue after oral administration, 400 mg curcumin intake 
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yielded a significant amount of radio-labeled curcumin signals (23). However, more 
curcumin intake did not increase the levels, indicating the maximum tissue absorption is 
extremely low (23). The adsorption levels stopped following a dose-dependent trend at 
very low levels of curcumin intake. In the case C57B1/6J mice, when they were fed with 
0.2% curcumin diet for one week, then curcumin was withdrawal from the diet, their tissue 
curcumin levels decreased to undetectable levels after just six hours (6). i.p. injection also 
showed little success in curcumin tissue retention. According to Perkins et al, C-14 labeled 
curcumin was injected through i.p. and the curcumin tissue levels are monitored (24). Liver, 
kidneys, and intestinal mucosa showed the highest peak concentrations of curcumin after 
injection, while there were detectable nmol/g levels of drug uptake in the brain, heart, lungs, 
and muscles, but the drug levels in all those organs quickly dropped to 20-33% of the 
original concentration after only 4-8 hours (24).  
   Another reason for curcumin's poor bioavailability is high metabolism in the body. 
Major metabolites such as glucuronides of tetrahydrocurcumin (THC) and 
hexahydrocurcumin (HHC) are identified in rates (6). Asai et al concluded that major 
curcumin glucuronidation enzymatic activities in the kidneys and digestive tracts may 
result in blood being exposed to mainly metabolized curcumin (25).  
   Curcumin's poor bioavailability shown through poor serum concentrations, tissue 
distribution and presence of major metabolites greatly limit its clinical application and 
efficacy. Therefore, researchers have considered numerous delivery platforms, including 
the nanofibers, to maximize the bioavailability of the drug.   
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Figure 4 (13) schematic illustration of signaling pathways of LPS and cytokines (TNF-α). 
NF-κB is activated as the result of both events.  
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Figure 5 (9) p65 (RelA) is the main dimer of NF-B inhibited by curcumin 
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Figure 6 (9) IL-8 luciferase activity after MEKK-1 stimulation is inhibited by curcumin. 
IL-8 luciferase is associated with NF-B pathway activation. At the same time TPA-
responsive element activity is associated with NF-B but it is still modulated by 
curcumin.  
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Wound Healing 
 
Wound healing is one of the primary areas of focus in nanotechnology. 
Nanotechonogy enables ease in delivering wound healing promoting formulations. 
Nanoparticles, such as silver particles can be used to as an effective anti-microbial agent. 
Due to the small size of the nanoparticles and their surface area to weight ratio, nanoscale 
reaction and bactericidal activities are enhanced (1). Curcumin loaded nanoparticles are 
widely researched for wound healing. The ingredient itself not only has anti-bacterial 
abilities, but also anti-inflammatory and anti-tumor activities. The functions of curcumin 
and its anti-inflammatory is discussed in Curcumin Chapter. 
Wound healing is an extremely complicated mechanism and involves the 
interactions from many immune cells, pro-inflammatory cytokines, growth factor, and 
different types of extracellular matrices. Cutaneous Wound Healing by Singer et al. 
discusses in great details of the wound healing mechanism. According to the article, when 
a tissue is damaged, it undergoes complicated mechanisms including inflammation, 
epithelialization, granulation tissue formation, neovascularization, and wound contraction 
(2). Blood clots in forms of extracellular matrix, which favors cell migration (2). 
Infiltrations of neutrophils, monocytes, and macrophages fight against infection and start 
inflammation (2).  
Neutrophils migrate to wound site within the first 48 hours (3). Macrophage 
infiltration starts to dominate after 3 days while neutrophil count at wound begins to 
decrease (3). During the process of inflammation, many inflammatory cytokines, including 
tumor necrosis factor α (TNF-α), interleukin-1 beta (IL-1β), interleukin-2 (IL-2), and 
interleukin-6 (IL-6). Cytokines, such as interleukin-1 (IL-1), are especially important since 
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it prepares the wound for neutrophil migration, which is the immune system’s first step of 
defense mechanism (4). The production of different growth factors in keratinocytes and 
fibroblasts, including the vascular endothelial growth factor (VEGF), can be stimulated by 
the secretion of cytokines such as TNF-α and IL-1β (4). VEGF-A binds to two surface 
receptor tyrosine kinases KDR and Flt-1 (4), (5). In vitro, once bound to VEGF, KDR 
increases cell proliferation and survival (5). VEGF bound Flt-1 is responsible for 
chemotaxis and controlling vascular permeability (4), (5). Through comparing with the 
wound closure of macrophage depleted mice, it has also been experimentally proven that 
growth factor productions are crucial to wound healing (2).  
Although normal inflammation can benefit wound closure by promoting immune 
cell recruitment through cytokine production and cell immigration and proliferation 
through growth factor secretion, other sources suggest excessive inflammation can be 
counterproductive to wound healing. In Factors Affecting Wound Healing by Guo et al., 
the group proposed the concept of detrimental effect of prolonged pro-inflammatory 
cytokine exposure to the wound (6). Bacteria and endotoxins can force the wound to go 
into chronic inflammation phase where cytokines such as TNF-α are expressed for an 
extended period (6). This can increase the levels of matrix metalloproteases (MMPs) at 
wound site, which can cause excessive extracellular matrix degradation (6). High protease 
content can also mean growth factors may also be degraded at wound site (6).  
Additionally, while neutrophils clean the wound and help fight infection, they do 
not seem to contribute directly to the wound healing process. Excessive neutrophil 
activation can cause unnecessary elevation of pro-inflammatory cytokines and reduced 
production of growth factors (7). In Inflammation and Wound Healing by Tatiana 
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Oberyszyn, the review article suggested that research has been done to deplete neutrophils 
in lab animals (8). While the wound healing had to be kept sterile to prevent infection, 
neutrophil depleted mice had more accelerated wound closure than normal mice, 
suggesting while neutrophil infiltration and inflammation can have adverse effect on 
wound closure (8), (9). Martin et al. investigate on the mechanism further and observe 
intact the wound healing process in PU.1 knockout mice (10). PU.1 null mice are depleted 
of both neutrophils and macrophages. Scaring is significantly reduced after neutrophil and 
macrophage depletion (10). Inflammatory cytokines such as IL-6 are absent due to the 
absence of immune cells, but crucial growth factor TGF-β is not missing in PU.1 null mice, 
though the growth factor levels are reduced due to macrophage absence (10). The fact PU.1 
null mice healed without scarring may have suggested that excessive cytokine and growth 
factor production might be the reason for unnecessary “matrix deposition and scar 
contracture post-repair”, according to Martin et al. (10).  
Other than immune cell infiltration and inflammatory cytokine and growth factor 
production, cell epithelialization also happens rapidly after a wound is created. Inter-
cellular links, such as hemidesmosomal, between dermal and epidermal cells are broken 
down to allow movement of the cells along the extracellular matrix (2). Epidermal cells 
possess integrin receptors on membrane to attach and adhere to extracellular matrix 
proteins from the blood clot (2). At the same time, the production of collagenase and 
plasmin are stimulated by epidermal cells to degrade the extracellular matrix made by 
blood clot, which is later replaced by fibroblast extracellular matrix (2), (11). After the 
epidermal cells start to degrade the extracellular matrix from blood clot, fibroblasts cells 
in the form of granulation tissues move into the wound site (2). The cells start producing 
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collagen and replace the existing extracellular matrix with collagenous matrix (2). After 
collagen is sufficient to cover wound area, the fibroblasts stop collagen production and 
undergo apoptosis (2). Unwanted activation of neutrophils can over-produce enzymes that 
can break down tissues at wound site, leading to even more neutrophil recruitment, a 
positive feedback loop (7). As a result, granulation tissue re-formation stage of wound 
healing can be severely hindered due to the fact that the new collage extracellular matrix 
will also be broken down. 
Due to their unique structure and thin diameter, nanofibers become increasing 
desirable wound closure treatment. They can mimic the extracellular matrix in the blood 
clot as well as the collagen stages, which support cell migration and proliferation in wound 
healing. In addition to their inherent ability to promote wound healing, different drugs and 
formulations can be loaded into the fiber membrane to further ease wound healing process. 
Many groups have successfully loaded surfactants into polymer nanofibers to modify the 
fibers’ hydrophobicity, which can enhance cell adhesion. Growth factors have also been 
coated on the cell surface to mimic growth factor secretion from the macrophage cells.  
On Sook Hee Ku et al., the group separately coated gelatin and poly (dopamine) 
(PDA) onto polycaprolactone (PCL) fibers in the effort to promote cell growth. They first 
start by observing the change in hydrophobicity by measuring the static contact angle when 
a drop of water rests on the surface to each fiber sample (12). The PCL fibers themselves 
are extremely hydrophobic, resulting in larger contact angles with the water droplet. The 
angles for PCL fibers and PCL homogenous film are 92. ° and 83°, respectively (12). 
When the nanofibers are coated with gelatin or PDA, they become hydrophilic and, 
28 
 
 
 
consequently, absorb water immediately onto their surface, minimizing the contact angle 
to zero (12).  
Human umbilical vein endothelial cells (HUVECs) are also cultured on the sample 
surfaces to investigate cell viability and proliferation (12). Even though both gelatin and 
PDA-coated nanofibers increase the hydrophilicity of the fibers, HUVECs attach and 
proliferate a lot better on the latter. The cell morphology can be shown in Figure 10 A (12). 
Because of the hydrophobic nature of bare PCL fibers, fewer cells adhered on the 
nanofibers, and for those that are attached, less area is occupied by each cell on the fiber 
surface (12). Cell count revealed that there is little difference between gelatin-coated and 
bare PCL nanofibers, whereas PDA-coated fibers acquired a significantly larger number of 
cells (Fig. 3.4B) (12). Cell viability (MTT) assay also showed a dramatic boost of cell 
viability in the PDA-coated nanofibers sample compared to bare PCL fibers (Fig. 3.4C) 
(12). One can conclude from their results that nanofibers not only provide a perfect 
platform for cell adhesion and growth, but also allow a platform to include more cell 
adhesion promoting materials, which further increase cell viability and proliferation. 
Other than coating growth factors and pro-adhesion materials on the nanofiber 
surface, the fibers can also be used to act as a drug delivery platform to deliver and control 
the release of anti-bacterial, anti-cancer, or anti-inflammatory drugs. Nguyen et al 
investigated the wound healing efficacy of curcumin-loaded poly lactic acid (PLA) 
nanofibers (13). The curcumin has long been researched and used as an effective anti-
inflammatory and anti-tumor agent, but due to its poor solubility in water, the drug has 
limited bioavailability in free form (14). The group dissolved both curcumin and PLA into 
organic solvent (chloroform/DMAc) and spun the solution into nanofibers with diameters 
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560-970 nm (13). C2C12 mouse myoblast cells are cultured on the surface of the nanofibers 
at different curcumin loading (13). Cell viability assay reveals that PLA fibers have some 
negative impact on viability (Figure 9) (13). Though the effect is not significant, the group 
conclude it can be attributed to the fibers high hydrophobicity, a problem that can be easily 
amended by coating hydrophilic material on the surface as performed in Ku et al. (12), (13). 
While moderate curcumin loading does not seem to have major impact on viability, 
increasing the curcumin content shows decreasing trend in viability (13). Higher curcumin 
content (>25uM) can even be toxic to the cells (13). Cell attachment assay also showed 
very similar results (Figure 10) (13).  
The group further investigated the in vivo wound healing efficacy (13). C57BL/6 
mice were used to observe the effects of different treatments (13). Burned skin wound is 
created by pressing a 7mm disk to the back of the mice (13). The wounds are created by 
blank PLA fibers and curcumin loaded PLA fibers (13). The efficacy is observed over the 
period of 15 days, and the wound closure images are shown in Figure 11 (13) and the 
quantitative wound closure rate are presented in Figure 12 (13). According to the figures, 
even the blank PLA provided efficacy for wound healing (13). Mainly because PLA 
provides the same structure as the provisional and collage extracellular matrices. The great 
biocompatibility of PLA and the structure’s porosity can also help cell attachment on the 
fiber membrane surface (13). But more importantly, according to Figure 12, though the 
differences are not as significant at the end of 15 days, curcumin fibers are the only group 
which completely close the wound (13). Additionally, curcumin fibers provided significant 
efficacy during the early stage of the healing trial (13). Despite of the small difference in 
the wound healing rate at the end of the trial period, through the pictures, the group also 
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concluded that the epithelialization stage of wound healing was almost done in the 
curcumin loaded fiber group within 7 days while the control group took over 15 days to 
complete the stage (13). Unfortunately, the group did not include further information about 
the healing process beyond day 15, but since the curcumin fiber group was at least 8 days 
ahead of the control group, large difference in total wound closure between the two groups 
can also be expected. As a side note, the group also discovered that the wounds from all 
mice in the curcumin group healed completely with relatively less scarring (13). This can 
be contributed to the fact that other than the anti-inflammatory effects of curcumin, it is 
also able to promote cell mobility and re-epithelialization at the early stage of wound 
healing because of its ability to induce hexosamine and uronic acid production (13), (15).  
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Figure 7 (12) surface modification of nanofibers changes the surface hydrophobicity and 
hence the contact angle with water 
 
 
Figure 8 (12) surface modified nanofiber provides an excellent platform for cell 
proliferation.  
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Figure 9 (13) hydrophobic surface of the nanofibers can negatively impact cell viability. 
Also, higher curcumin loading could decrease cell viability as well.  
 
Figure 10 (13) higher curcumin content (>25 uM) can negatively impact cell proliferation 
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Figure 11 (13) PLA nanofibers can accelerate wound healing due to its ECM mimicking 
structure. Curcumin loaded PLA nanofibers can promote wound healing even further due 
to various anti-inflammatory effects of curcumin.  
 
Figure 12 (13) wound closure rates from control (no treatment), PLA nanofibers, and 
curcumin loaded PLA nanofibers  
34 
 
 
 
Wound Healing References 
 
1.  "Nanotechnology accelerates wound healing." Dermatology Times. Advanstar 
Communications Inc, n.d. Web. 13 Feb. 2017. 
2. Epstein, F. H.; Singer, A. J.; Clark, R. A. New England Journal of 
Medicine 1999, 341 (11), 738–746. 
3. Leibovich SJ, Ross R. The role of the macrophage in wound repair: a study with 
hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71-100. 
4. Barrientos, S.; Stojadinovic, O.; Golinko, M. S.; Brem, H.; Tomic-Canic, 
M. Wound Repair and Regeneration 2008, 16 (5), 585–601. 
5. Wang, D. Journal of Biological Chemistry 2000, 275 (21), 15905–15911.  
6. Guo, S.; Dipietro, L. A. Journal of Dental Research 2010, 89 (3), 219–229. 
7. Menke, N. B.; Ward, K. R.; Witten, T. M.; Bonchev, D. G.; Diegelmann, R. 
F. Clinics in Dermatology 2007, 25 (1), 19–25. 
8. Oberyszyn, T. M. Frontiers in Bioscience 2007, 12 (8-12), 2993. 
9. Dovi, J. V. Journal of Leukocyte Biology 2003, 73 (4), 448–455. 
10. Martin, P.; D'souza, D.; Martin, J.; Grose, R.; Cooper, L.; Maki, R.; Mckercher, S. 
R. Current Biology 2003, 13 (13), 1122–1128. 
11. Pilcher, B. K.; Dumin, J. A.; Sudbeck, B. D.; Krane, S. M.; Welgus, H. G.; Parks, 
W. C. The Journal of Cell Biology 1997, 137 (6), 1445–1457. 
12. Ku, S. H.; Park, C. B. Biomaterials 2010, 31 (36), 9431–9437. 
13. Nguyen, Thuy Thi Thu, Chiranjit Ghosh, Seong-Gu Hwang, Lam Dai Tran, and 
Jun Seo Park. "Characteristics of curcumin-loaded poly (lactic acid) nanofibers for 
wound healing." Journal of Materials Science 48.20 (2013): 7125-133. Web. 
14. Manju, S., and K. Sreenivasan. "Conjugation of curcumin onto hyaluronic acid 
enhances its aqueous solubility and stability." Journal of Colloid and Interface 
Science 359.1 (2011): 318-25. Web. 
15. Panchatcharam, Manikandan, Sumitra Miriyala, Vinaya Subramani Gayathri, and 
Lonchin Suguna. "Curcumin improves wound healing by modulating collagen and 
decreasing reactive oxygen species." Molecular and Cellular Biochemistry 290.1-
2 (2006): 87-96. Web. 
  
35 
 
 
 
Cell Membrane Coating and Nanofiber Attachment 
 
Nanoparticle cell membrane coating technology was first developed by Dr. 
Liangfang Zhang in effort to produce a biomimetic system that improves in vivo circulation 
time while minimizing the traditional downsides of using conjugates. Before the 
emergence of membrane camouflaged nanoparticles, conjugation of polyethylene glycol 
(PEG) was used to solve most drugs poor circulation problems. PEG was first discovered 
by FF Davis et al in 1977 in his paper Alteration of Immunological Properties of Bovine 
Serum Albumin by Covalent Attachment of Polyethylene Glycol (1). The group modified 
a typical immunogenic protein, bovine serum albumin (BSA), by blocking the functional 
groups on the surface with nonimmunogenic polymer chains and made it nonimmunogenic 
(1). The size of the molecule also dramatically increased so that renal clearance is 
minimized (1). Because of PEG's simple production process and proven efficacy, it became 
one of the most widely used medium for improving in vivo circulation. Although 
PEGylation shows attractive efficacy, researchers gradually realized that certain key 
drawbacks prohibit the adoption of the technology. According to Fan Zhang et al., the 
nonimmunogenic promise of the conjugate is not full-proof; the benefits do not come 
without consequences (2). One of the main downfalls of using PEG is the concern over 
developing anti-PEG anti-body. According to Sroda et al., PEG will not remain 
nonimmunogenic for long if the a biological system is exposed to repeated doses (3). 
Repeated injection of PEG can trigger the immune response and stimulate the biological 
system to produce PEG antibodies (3). In their experiments, the detection of 
carboxyfluorescein (CF) was used to represent the immunoreactivity under PEG 
stimulation (3). Three groups of PEGylated liposomes were incubated with 10 mM HEPES 
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and 140 mM NaCl solution, serum from rabbits not exposed to PEG, and serum from 
animals that have been injected with PEG-liposomes for 7 consecutive days (3). The results 
from CF assay showed that CF intensity is the highest from the third group, with the first 
group being the lowest of that (3). This indicates presence of immune response to PEG-
liposomes after repeated exposure.  
Zhang et al used the structure of red blood cell membranes to cloak nanoparticles 
so that the immune system fails to recognize them as foreign objects. The body undergo 
phagocytosis when encountering foreign objects in the system (4). Phagocytes do not 
engulf non-foreign cells mainly because a marker CD47 is expressed on most cells (4). 
Tsai et al. conducted experiments comparing the phagocytosis activity with bare 
microbeads and those coated with CD47 (4). The result showed that the majority CD47 
coated beads were able to avoid phagocytosis in both cases of human and mouse CD47's 
(4). Bioconjugation of CD47 has not been successful in preventing protein denaturization 
(5). Red blood cells are natural carriers in the body for oxygen delivery. Membrane coated 
nanoparticles are able to demonstrate an even longer circulation half-life than PEGylated 
nanoparticles while avoiding possible production of antibodies (5). Human and mouse red 
blood cells express CD47 on the membrane surface so the derived membranes preserve 
those markers and can camouflage biocompatible materials through membrane coating (6). 
Membrane coating can offer benefits other than improving circulation in the system. 
Different cell membrane type can offer specific functions to achieve various clinical 
efficacies. For example, RBC generally are the most available and Dr. Liangfang Zhang's 
lab has done extensive research on RBC membrane coated particles. In the case of RBC 
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membrane coating, the nanoparticles are also able to neutralize a broad spectrum of pore-
forming toxins (7). According to Zhang et al., RBC membrane coated poly(lactic-co-
glycolic acid) (PLGA) nanoparticles are able to reduce or, in some cases, completely avoid 
lysis of red blood cells from most pore forming toxins, including α toxin (7). α-toxin lyses 
the red blood cells through anchoring its molecules on the cell surface (8). Molecules can 
link each other through non-covalent interactions and form pores that exposes intracellular 
fluid to outside environment, causing cell death (8). Those toxins can have similar or 
identical effects on RBC membrane coated nanoparticles but due to the nanoparticles' high 
surface area, attachment onto the nanoparticle surface can be more favorable than that of 
the cells in theory. In Figure 13a and b, through both qualitative and quantitative data, RBC 
nanoparticles are able to protect the cells from being lysed while all other formulations fail 
(7). Blotting (Figure 7d) also shows toxin binding on both RBC vesicle and RBC 
membrane coated particles (7).  
Cell membrane coating technology can also be used for detoxifying chemical toxins 
such as organophosphates. According to Kroll et al., organophosphates, commonly seen as 
commercial pesticides, work by phosphorylating acetylcholinesterase (AChE), which is 
responsible for inhibiting the degradation of acetylcholine (ACh), a neurotransmitter (9). 
RBC membrane coating can reduce the toxic effects by allowing the chemical to attack the 
acetylcholinesterase provided by the cell membrane (9). The illustrations of the RBC 
membrane NPs' role in preventing dichlorvos (DDVP), a type of organophosphate, from 
inhibiting AChE and leading to accumulation of ACh in the synapse are shown in Figure 
14 (10).  Pang et al., mice was given lethal intravenous injection of DDVP (10 mg/kg) (10). 
Then, three different groups were given no treatment (PBS), PLGA-PEG NP and RBC NP, 
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respectively (10). The first two groups reached 100% death within 12 mins, whereas, RBC 
NP group had zero fatality (10). Orally administration (150 mg/kg) also showed similar 
results, with the RBC NP group being able to prevent any death by the organophosphate 
(10).  
In addition to the use of RBC membrane for pore-forming toxin neutralization and 
organophosphates, other membranes are used to fit other purposes. For example, 
macrophage membranes have been used to neutralize cytokines and endotoxins 
(lipopolysaccharide (LPS)) (11). The functions of those membrane receptors and their 
signaling pathway have been discussed in detail in the Curcumin chapter. Because 
macrophage cells have surface receptors that bind to cytokines and LPS (e.g. TNFR 
receptor for TNF-α and TLR-4 receptor for LPS), by retaining only the cell membrane and 
its receptor proteins, endotoxins and cytokines can be adhered onto the membrane without 
additional inflammatory response, in turn, removing them from the surroundings.   
According to Thamphiwatana et al., the group confirmed the preservation of 
various macrophage membrane proteins on the surface of the macrophage membrane 
coated PLGA nanoparticles, including CD14, CD284 (TLR4), CD126(IL6R), CD130, 
CD120a, and CD120b (TNFR1 and TNFR2), through western blotting (11). Among them, 
CD13 and CD284 are responsible for LPS binding; CD126 and CD130 are responsible for 
IL-6 binding; and CD120a and CD120b are responsible for TNF-α binding. The 
macrophage nanoparticles are also proven to absorb LPS, IL-6, TNF-α, and IFN-γ (11). 
LPS absorption is in the range of several hundred nanograms per milligram of nanoparticles, 
while in the cases of almost all cytokines, the absorption amount is in picograms (11). 
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Because their capabilities of taking cytokines and LPS away from the environment, it can 
have anti-inflammatory properties. The production of intracellular reactive oxygen species 
can be stimulated after LPS exposure. Intracellular nitric oxide (NO) production was 
determined for LPS stimulated J774 cells treated with PBS, PEG NP, RBC NP, and 
Macrophage NP (11). Among all groups, the macrophage NP group expressed the lowest 
amount of NO production (11). Human umbilical vein cells (HUVECs) were incubated 
with FITC conjugated LPS (FITC-LPS) and FITC-LPS treated with macrophage 
nanoparticles (11). Both fluorescent microscopy and flow cytometry results showed less 
fluorescent signal from the cells in FITC-LPS/macrophage NP group (11). The data 
implied when the surrounding LPS solution was treated with macrophage NPs, the particles 
absorbed majority of the LPS so that there is less FITC-LPS available for the cells to bind. 
Human embryonic kidney (HEK)-BLUE hTLR4 reporter cells were also used to determine 
the extent of TLR4 activation (11). Again, Macrophage NPs showed the lowest amount of 
receptor activation (11). In vivo anti-inflammatory studies also showed that Macrophage 
NP are able to reduce systemic inflammation in mice after tail-vein injection of LPS, with 
the macrophage NP reducing both TNF-α and IL-6 levels 3 hours post-injection (11). 
Consequently, chance of death by septic shock is also reduced compared to all other groups, 
shown through the survival study (11).  
Membrane coating technology provides many features that can be useful for 
research and clinical purposes. It can become even more versatile when combining with 
other nanosystems, for example, the nanofibers. Cell membranes carry negative zeta-
potentials, a feature that is highly exploitable for attaching cell membrane NP on to 
nanofibers, allow the combination of two powerful nano-systems.  
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Chen et al. discovered when the polycaprolactone (PCL) fibers were loaded with 
1% poly-D-lysine, they were able to attract beta cell membranes and allow them to adhere 
onto the fiber surface (12). Fluorescent imaging, immunostaining, and bicinchoninic acid 
assay (BCA) have confirmed membrane loading onto the fiber surface (12). Water contact 
angles have also improved to show better hydrophilicity, which implies it can improve cell 
proliferation on the surface (12). Pancreatic beta cell lines MIN6 proliferation assay 
consequently showed better cell proliferation on membrane coated fibers compared to 
uncoated nanofibers and bare glass cover glass (12). Cell viability also improved in terms 
of showing higher levels of insulin secretion in the membrane coated fiber group (12). 
Chen et al also briefly explored the possibilities of beta cell membrane coated PLGA NPs 
in addition to direct membrane adhesion, and fluorescent signals confirmed similar 
adhering phenomenon as well (12).  
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Figure 13 (7) RBC membrane coated PLGA particles are able to prevent hemolysis 
caused by -toxin 
 
Figure 14 (11) RBC membraned coated PLGA particles can serve as a decoy binding site 
for DDVP, preventing the inhibition of AChE 
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Experimental Methods: 
 
Nanofibers: 
Polycaprolactone (PCL) nanofibers were prepared using the electrospinning 
method. The polymer crystal and ciprofloxacin were purchased from Sigma-Aldrich. 
Curcumin from Acros organics, and Poly-L-lysine Hydrobromide from Nordic Biolabs. 
PCL was dissolved in 7:3 mixture of formic acid and acetone at concentration 0.1 mg/ml. 
Curcumin, ciprofloxacin, and poly-L-lysine were added at concentrations 3%, 1%, and 4% 
to PCL weight, respectively. The content was stirred using a magnetic stir bar for 2 hours 
or until all solid was dissolved. Mixture was then transferred to a syringe equipped with a 
blunted needle (BD PrecisionGlide Needles 23G x 1 1/2). The polymer solution loaded 
syringe was installed on a syringe pump (New Era Pump Systems Inc). A Teflon coated 
Aluminum baking foil was used as the sample collector placed 12 cm away from the tip of 
the blunted needle. And an electric field of 20 kV was placed between the needle and the 
collector. Polymer solution was pumped out at a rate of 0.4 ml/hr into the electric field. 
After electrospinning, the sample was left to dry in the fume hood overnight. Fiber 
membrane sample was lifted from the collector. Fiber morphology was observed using 
optical microscopy (EVOS FL) and scanning electron microscopy (SEM). Fiber diameters 
were collected through measuring 200 randomly selected fibers samples from the SEM 
fiber images with ImageJ. Other polymer concentrations were also explored with their 
effect on fiber morphology examined using an optical microscope.  
PLGA nanoparticle cores: 
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Poly (lactic-co-glycolic acid) (PLGA) nanoparticles were prepared using 
nanoprecipitation method. PLGA crystals were placed in acetone or acetonitrile solvent at 
concentration 20 mg/ml. DiD labeling dye was added to the mixture at ≤ 1 μ g/ml 
concentration when DiD dye labeling was desired. The resulting content was stirred using 
a magnetic stir bar for 30 mins or until the content dissolves. The mixture was then pipetted 
rapidly to 2 ml 10mM Tris-HCl/water solution. The residual organic solvent was removed 
by force convection until all traces of organic solvent was evaporated. Loss volume through 
evaporation was re-compensated through adding additional water till a final volume of 2 
ml was achieved. The final nanoparticle suspension was at 10 mg/ml and sizes are verified 
using dynamic light scattering (DLS). 
J774 Cell Culture 
A mouse macrophage cell line, J774 was purchased from Sigma-Aldrich and 
cultured in 10% Fetal Bovin Serum (FBS) (Hyclone) and 1% penicillin-streptomycin 
(Invitrogen) in Dulbecco’s Modified Eagle Medium (DMEM), purchased from Invitrogen. 
Cells were cultured in T-175 suspension culture flasks until 90% confluency and detached 
by adding 2 mM EDTA/PBS solution and incubating at 37°C for 5 mins. Harvested cells 
were stored at -80 °C  in DMSO freezing medium (Sigma-Aldrich) until membrane 
derivation.  
Cell Membrane Derivation: 
 Cell membrane derivation using the hypotonic lysing method. The cells were 
washed twice with starting buffer (20.5g sucrose, 13g sucrose, 15 ml 1M Tris-HCl, in 500 
ml distilled water) and spun down at 800 rcf for 5 minutes. The pellet was washed twice 
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through centrifugation with isolation buffer (150 uL EGTA (ethylene glycol-bis(β-
aminoethyl ether)-N,N,N',N'-tetraacetic acid) 100 mM, 100 uL protease inhibitor, and 100 
uL phosphate inhibitor in 30 mL starting buffer) and homogenized using a probe 
homogenizer for 15 passes. The spun down pellet was re-suspended and homogenized 
again. All contents were centrifuged down with the ultra-centrifuge at 7,600 rpm for 25 
mins (SW32Ti rotor). The supernatant was washed twice with the storage buffer (2 uM 
EDTA in water) using the ultra-centrifuge to spin down at 29,600 rpm for 35 mins. The 
membrane protein content was quantified using the bicinchoninic acid (BCA) assay.  
Cell membrane coating and nanofiber attachment: 
 Cell membranes and PLGA nanoparticle cores were combined with the ratio of 1:1 
membrane protein to polymer weight. The mixture was sonicated in a bath sonicator 
(Fisher Scientific) for 3 minutes or until the content was no longer opaque. Nanofiber 
weight was predetermined using a micro balance (####). Coated nanoparticles were then 
incubated with the nanofibers overnight at 37°C. The liquid was discarded and fibers 
washed with a sufficient amount of DI water to remove excess nanoparticles. And the NP 
attached nanofibers were dried in a vacuum chamber overnight.  
 After attachment, triplicated nanofiber samples were put in ultra-pure water and 
sonicated using a probe sonicator (Fisher Scientific) until the samples were broken into 
small pieces that disperse homogeneously in the sample solution. Then three separate liquid 
samples were taken out for protein content quantification using the BCA assay. The protein 
content was then normalized by the fiber weight.  
Nanoparticle binding stability study 
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 A triplicated set of fiber samples were placed in PBS under continuous shaking at 
37°C. liquid was taken out at each time point and its protein content measured with the 
BCA assay. At the end of the study, each of the samples were washed using DI water and 
sonicated with the probe sonicator until fiber pieces are thoroughly broken down in water. 
Protein content was measuring with the BCA assay.  
Curcumin release study 
 Fiber samples were put in dialysis cups (pore size: 20 kDa) and soaked in 3 L of 
PBS while being shielded from light and under continuous shaking. The surrounding PBS 
was constantly replaced with fresh PBS to minimize saturation. At predetermined time 
points, a set of triplicated samples was taken out and dissolved in a fixed amount of 
acetonitrile. A curcumin standard curve was also made using acetonitrile as a solvent. 
Curcumin concentration quantification was measured through determining the curcumin’s 
fluorescent signal using a plate reader (excitation 488 nm, emission 515 nm). 
Ciprofloxacin release study 
A set of triplicated nanofiber samples were placed in the dialysis cups in 500 ml 
PBS at 37°C  while being shielded from light and under continuous shaking. At 
predetermined time points, 100 uL of PBS was taken out of the container, and the same 
volume was replenished with fresh PBS. The ciprofloxacin content in each PBS sample 
was measured using a plate reader (excitation 272 nm, emission 448 nm). At the end of the 
release trial, the three fiber samples were dissolved in acetonitrile and the remaining 
ciprofloxacin content was also determined by reading ciprofloxacin fluorescence.  
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Ciprofloxacin anti-bacterial study: 
 The anti-bacterial study of the ciprofloxacin loaded nanofibers were measured 
through both inhibition in medium using optical opacity and biofilm colony size 
experiments. 
 For the inhibition study, Escherichia Coli (E. Coli) was grown in lysogeny broth 
(LB) overnight. The bacteria count was adjusted to 5×106 CFU (colony-forming unit) (0.08 
OD), and 100 uL of solution was added to each clear cuvette. For the minimum inhibition 
concentration (MIC) study, serial dilutions of the ciprofloxacin in LB broth were added in 
the clear cuvettes at 1ml each. For nanofiber anti-bacteria study, nanofibers were incubated 
directly in 1 ml LB broth and 100 uL bacteria solution as described above. All mixtures 
were incubated at 37°C for 24 hours under continuous shaking. At the end of the incubation 
period, fibers were removed from the medium and bacteria content in terms of optical 
density (OD) was measured with a biophotometer (Eppendorf D30).  
 For the biofilm study, E.Coli was grown overnight in LB broth then diluted to 
desired concentration (1.6× 10 CFU/ml). Fiber samples were sanitized under UV light 
for 30 mins then placed on an agar medium plate. 5 uL of diluted culture was placed on 
each of the samples. Plates were incubated for 24 hours at 37°C . Samples were then 
transferred to a fresh agar plate and incubated again for 24 hours. The samples were 
vortexed to detach all bacteria and diluted culture re-seeded onto an agar plate from which 
the colony forming units per fiber sample were determined.  
In vitro cell proliferation on nanofibers 
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Fiber samples were electrospun onto circular cover glass to ensure identical surface area. 
Human Foreskin Fibroblast (HFF) cells were seeded onto the fiber in a 12-well plate at 
5 × 10 cells/well. At each predetermined time point, a triplicated sample set was 
trypsinized and cells removed from the fibers. The resulting cell suspension was analyzed 
using a hemacytometer (Fisher Scientific) for cell count. For fluorescent imaging, the cell 
cytoplasm was stained with Carboxyfluorescein succinimidyl ester (CFSE) before seeded 
into the well plate. After proliferation, cells were fixed using 10% formalin. The nucleus 
was stained with Hoechst fluorescent stain (Thermo Fisher). The cover slips were observed 
under confocal microscopy.  
ROS detection using DCF-DA Assay: 
Intracellular Reactive Oxygen Species (ROS) production is measured using the 2’,7’ 
–dichlorofluorescin diacetate (DCFDA) assay kit manufactured by Sigma-Aldrich. J774 
macrophage cell line was used in this experiment. 2500 cells were seeded into a 96-well 
plate and cultured overnight. At the same time, samples were incubated with 50 ng/ml of 
LPS (in DMEM medium) to allow endotoxin removal by the formulation. LPS was spun 
down and supernatants collected. Cells were then exposed to the supernatants and 
incubated for 24 hours to allow sufficient ROS production. A10 mM hydrogen peroxide 
solution was used as the positive control. The cells were gently washed with phenol red 
and serum free DMEM three times and soaked in the medium for 6 hours to remove excess 
phenol red. After the medium was removed, DMEM containing 10 mM HEPES and 5 uM 
DCFDA was added to the cells and incubated for half an hour. The cells were washed for 
another two more times with phenol free medium. Lastly, fresh medium was placed in the 
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well-plate and incubated with the cells at 37°C. Fluorescence from DCF was detected using 
a plate reader (BioTek) (excitation: 488nm, emission: 515 nm) 
Cytokine absorption: 
 IL-6 and TNF-α absorptions by attached macrophage nanoparticles were measured 
in this project. Specifically, 500 ng of IL-6 or TNF-α in 10% FBS/PBS was exposed to the 
formulation for 30 mins at 37 °C. The control group contained only the cytokine solution. 
Supernatant was taken out and spun down at 16,100 rcf for 10 mins to remove possible 
fiber debris and loosely attached nanoparticles. The cytokine levels in these clear 
supernatants were quantified using the Enzyme-linked immunosorbent assay (ELISA).  
Cytokine expression using ELISA (in vitro anti-inflammatory effect)  
 J774 cells were seeded at 1 × 10 cells/matrix in a 96 well plate and incubated 
overnight to allow attaching. Formulations were also incubated with 50 ng/ml LPS in 
DMEM for 30 mins to allow LPS absorption. Afterwards, the fibers in each sample were 
collected and the liquid mixture spun down at 16,100 rcf for 10 mins. The fibers and 
supernatant were transferred to their corresponding wells and incubated with the cells for 
8 hours. Afterwards, the medium was collected and spun down to remove any fiber and 
particle debris. The cytokine concentration in each medium sample was quantified using 
ELISA.  
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Results and Discussion 
 
Characterization and formulation: 
The preparation of the macrophage nanoparticle attached nanofibers (MϕNPNF) is 
based on well-established nanofabrication methods and involves several important steps. 
The mouse J774 cell line was used as a source for cell membranes. Cells were cultured and 
lysed for cell membranes through processes involving hypotonic lysing and 
ultracentrifugation. The high quality and preservation of surface receptor proteins of the 
membranes yielded from those processes have been confirmed by multiple sources (1), (2). 
PLGA polymeric nanoparticle cores, prepared using nanoprecipitation, was used as 
membrane structural support to keep the membranes from collapsing onto the nanofibers. 
Sizes of the PLGA cores were analyzed under DLS and have an average size of 80 nm. 
Membranes were coated onto nanofibers through sonication as previously described. The 
correct receptor protein orientation was also confirmed with the group’s previous work (2), 
(3). Coated PLGA cores were again measured by DLS for diameters. An average diameter 
of 110 nm was obtained. Thamphiwatana et al. showed that the macrophage membrane 
coated cores were stable in PBS for more than two weeks (3). PCL Nanofibers were 
prepared from the electrospinning method with 10% polymer in solvent and yielded 
nanofibers containing 3% (w/w) curcumin and 1% (w/w) ciprofloxacin. Macrophage 
membranes coated nanoparticles (MϕNP) were incubated with nanofibers for 1 hour, after 
which excess and loosely attached nanoparticles were washed away using deionized water. 
Attachment is confirmed using fluorescent microscopy while MϕNPs are labeled with dye 
DiD and nanofiber are detected using curcumin’s fluorescence (Figure 15). After 
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incubation and washing, fluorescent images with curcumin fluorescence (GFP channel 
Figure 15 left) in nanofibers and DiD fluorescence (CY5 channel Figure 15 middle) in the 
nanoparticles confirmed the co-localization of the nanoparticles and nanofibers (dual 
channel overlay Figure 15 right), with DiD signals spreading along the nanofibers. The 
fluorescent results indicate nanofiber surface binding of the nanoparticles. SEM images 
further confirmed the attachment by visually capturing individual nanoparticles on the 
nanofiber surface (Figure 16). SEM images show that nanoparticle attachment preserved 
the fibers’ smooth and fibrous morphology. Through observing the SEM microscopy 
images, one can conclude that the diameter distribution the fibers follows the typical 
Gaussian distribution with the mean at 135 nm, median 126 nm, and standard deviation 43 
nm (Figure 17).  
Poly-L-lysine is the main component in the fibers to attract cell membrane coated 
nanoparticles. All membrane proteins have negative zeta-potentials. Poly-L-lysine 
provides positively charged groups for the membrane proteins to interact through electro-
static interaction. The same principle was also used in cell culture flasks, which are treated 
with Poly-lysine at the bottom to provide more available sites for cell adherence. Since the 
cell membrane coated nanoparticles preserve most or all surface membrane proteins, 
similar electrostatic interactions should be expected from the coated nanoparticles. 
Therefore, poly-L-lysine loaded nanofibers should have the advantage of increasing the 
number of binding sites to the nanoparticles, though too much poly-L-lysine loading may 
affect fiber morphology because electrospinning depends strongly on the solution’s 
viscosity. PCL polymer solutions were then added increasing amount of poly-L-lysine, and 
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the fluorescent images in Figure 18 showed no significant morphological effect when fibers 
are loaded up to 4% (w/w) poly-lysine.  
The loading test was done by detecting the amount of nanoparticle loading through 
incubating concentrated M ϕ NP suspension (3.33 mg/ml polymer weight) with the 
nanofibers. After washing with distill water to remove excess nanoparticles, the fibers were 
then homogenized in fresh water using a probe sonicator until the fiber pieces are small 
and homogenously suspending in water. Protein concentration in the homogenized samples 
were then quantified using the BCA assay. 0%, 1% and 4% (w/w) poly-lysine loadings 
were used in the test (Figure 19). 0% yielded less than 1% average nanoparticle loading. 
This is simply due to the lack up binding sites for charge interaction on the fibers. 1% 
polylysine showed a slight but insignificant increase. Lastly 4% poly-lysine was able to 
retain up to 10% nanoparticles. Loading test clearly showed an increasing amount of 
retained nanoparticles from increasing amount of particle loading.  
Nanoparticle stability and drug release: 
The stability of the electrostatic interactions in PBS was measured. Samples were 
incubated with 1x PBS at 37 C under continuous shaking for 3 days. And at predetermined 
time points, a triplicated set of fiber samples was taken out of the buffer solution and 
homogenized with a probe sonicator. The BCA assay was used to detect the protein content 
in the homogenized solution. The poly-L-lysine loaded fibers provide an excellent platform 
to retain the nanoparticles. From the results in Figure 20, the system presented negligible 
nanoparticle loss in the first 24 hours. Noticeable release occurred between 24 and 72 hours. 
After 48 hours, the system loses about half of the all attached nanoparticles. After 72 hours, 
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the final retained nanoparticles decreased to 2.19 ± 1.00% (w/w) of the fiber weight. 
Fortunately, endotoxin and cytokine bindings usually complete within 30 minutes of 
contact. Therefore, the particle retention provides enough time to absorb pro-inflammatory 
cytokines at the site of nanofiber implantation.  
The antibiotic ciprofloxacin was loaded 1% (w/w) to fiber weight and its release 
mechanism was investigated by incubating known amount of fiber samples with 100 ml 
PBS under 37 C. The solution was constantly stirred. The change of ciprofloxacin 
fluorescent signal was observed and the absolute amount quantified with a standard curve. 
The amount of drugs within the fibers before and after the release trial was quantified by 
dissolving the fibers in acetonitrile and measuring fluorescent signal. The results are shown 
in Figure 22. The system releases about half of its loaded drug in merely 1 hour and up to 
75% after 2 hours. Within 24 hours, the system releases up to 100% of the drug. After 36 
hours, all tested samples contained barely detectable amount of ciprofloxacin in the fibers. 
Ciprofloxacin released quickly from the nanofiber mesh mainly due to its solubility in 
water and lack of retention component in the formulation.  
The release of the third component in the system, curcumin, was measured by 
incubating the multiple samples in the dialysis cups and dialyze against large volumes of 
PBS. All samples were shielded completely from light. At each time point, a set of 
triplicated samples were taken out of the container and dissolved in acetonitrile. The 
fluorescent signal was observed and quantified using a free curcumin standard curve. The 
experiments were done in both 25 C and 37 C under continuous shaking. Results can be 
seen in Figure 21 Curcumin has minimal solubility in water so the release of curcumin is 
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mainly dominated by solid diffusion, and the mechanism can be strongly depended on 
temperature. At 25 C, samples showed negligible release at the end of 48 hours. The 
curcumin content in all tested sample showed little to no statistical difference from each 
other. However, when the release condition was changed to 37C, the diffusion mechanism 
dramatically sped up. The results showed an initial burst release of curcumin in the first 12 
hours with the concentration reaching below 50% of the original value after just 9 hours. 
After the burst release, it leveled off and released the drug relatively more slowly. At the 
end of 48 hours, overall retention of the drug was about 11.8 ± 3.9 %. Overall, the release 
of curcumin was significantly shower than ciprofloxacin due to its lower water solubility.  
Anti-bacterial efficacy of ciprofloxacin (Figures 24 and 25): 
Ciprofloxacin is a powerful antibiotic with significantly more efficacy and wider 
spectrum of activity than other common antibiotics such as norfloxacin and nalidixic acid 
(4). In fact, three major components in the nanofibers formulation are reported to have anti-
microbial efficacy. According to Y. Wang et al., curcumin is effective against various kinds 
of bacteria and has even more efficacy against fungi than bacteria (5). However, it has a 
very high mean inhibition concentration (MIC) of 250 μg/ml against E. Coli, a common 
gram-negative bacterium (5).  
Poly-L-lysine was also found to be anti-bacterial. The chemical is effective against 
many strains of gram-negative and gram-positive bacteria, including E. coli and S. aureus 
(6). Moreover, the conformation of the molecular structure can impact its efficacy 
significantly. Shima et al. discovered that ϵ-poly-L-lysine ϵ-PL is a lot more effective 
against all bacteria than α-poly-L-lysine (6). The MIC of ϵ-PL was checked by adding 
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serial diluted poly-lysine formulation into 5 × 10 CFU/ml E. coli in LB broth, and shaken 
overnight. Bacteria growth is quantified through observing optical density (O.D.). 
Unfortunately, ϵ-PL yielded relatively high MIC against E. Coli, with the estimated MIC 
at over 50 μg/ml. At 4% (w/w) poly-L-lysine loading, it is unlikely to show significant 
anti-bacterial efficacy from the fibers with the component alone.   
The same inhibition study was done with Ciprofloxacin as well. Being a highly 
effective anti-biotic, ciprofloxacin showed dramatically lower MIC to E. coli than either of 
the other components in the system at < 0.1 μg/ml. Given the nature of the drug’s release 
property as mentioned above, a minuscule amount of loading would be sufficient to inhibit 
the growth of E. Coli. After the formulation titration, the MIC of ciprofloxacin is found to 
be < 0.1μg/ml, which is 10 times lower than ϵ-poly-L-lysine and 2500 times lower than 
curcumin.  
 To observe the anti-bacterial effect of the loaded ciprofloxacin, three groups of 
triplicated nanofiber samples, poly-lysine only, poly-lysine with curcumin, and poly-lysine 
with curcumin and ciprofloxacin, were incubated with 5 × 10  CFU/ml E. coli at 37C 
under continuous shaking. The O.D. was observed after 24 hours. Even though poly-L-
lysine’s anti-microbial effect is well-documented, 50 μg/ml is well beyond the loading 
amount a 1 mg fiber sample could provide. Also, as expected, due to the high MIC of 
Curcumin to E. coli and its poor solubility in water, the formulation does not provide 
enough of the drug to inhibit bacteria growth. The antibiotic loaded sample could fully 
inhibit E. coli in LB broth, thanks to fibers’ fast release mechanism of ciprofloxacin and 
the drugs low MIC value to E Coli.  
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 The surface anti-microbial effect of the nanofibers was tested using E. coli biofilm. 
1 × 10 CFU E. coli was seeded on each of the fiber samples. The bacteria were grown on 
the sample surface overnight. At the end of the trial period, all samples were sonicated in 
LB broth to detach the bacteria and transferred to another agar plate to quantify colony 
counts. Poly-L-lysine only, and curcumin loaded fibers are not able to reduce bacteria 
growth in dry conditions either, despite of the lower liquid volume and higher local 
concentration compared to the previous study. Meanwhile, similar to the previous 
experiment, ciprofloxacin again provided the benefit of completely inhibiting and killing 
E. coli on the fiber surface, which almost no bacteria colony observed. Such property is 
especially useful when the system is used as a topical wound dressing. The added antibiotic 
is able to reduce or prevent bacteria growth at the wound site and hence reduce chances of 
infection. 
In vitro cell proliferation study (Figure 23): 
 Nanofibers are known to promote cell proliferation. As discussed in the previous 
sections, nanofibers provide a scaffold that mimics the extracellular matrix during wound 
healing process. As a result, cells are able to adhere and migrate more efficiently on the 
matrix. The poly-L-lysine component in the fibers is also able to enhance cell recruitment 
and attachment, similar to a tissue culture treated polystyrene flask.  
 In order to further verify the system’s capability to promote cell growth, human 
foreskin fibroblasts (HFF) were grown on the fiber surface. Surface area was controlled by 
electrospinning fiber sample directly onto a confocal cover slip (2 cm diameter) and using 
a bare cover glass slip as control. HFF cells were seeded onto the cover slips at 5 × 10 
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cells/matrix into a 12-well plate. Samples were taken every 24 hours by detaching cells 
using trypsin and counting with a hemacytometer.  
 Due to the excellent biocompatibility and fibrous structure of the nanofibers, HFF 
cells are able to proliferate well onto the sample surface. The cell count showed a 
significant boost of attached cells onto the nanofiber than bare cover slip (control group) 
alone. The difference in cell numbers became apparent after 24 hours of culture. After 72 
hours, the cells from the nanofiber group had almost 50% more cells than the control group, 
with more than 1.6 × 10  cells compared a mere 1.1 × 10  cells in the control group. 
Moreover, though the nanoparticles should not benefit cell proliferation, they have no 
negative impact on cell proliferation when integrated onto the fibers. The MϕNP attached 
nanofiber group showed no statistical difference in cell count with the nanofiber only group.  
 To visually observe the attached cells, HFF cells are stained with CFSE and 
Hoechst stain and imaged under confocal microscopy and imaged after 24 and 48 hours. 
Same trend can also be observed in the confocal images.   
In Vitro Cytokines and Endotoxin Neutralization (Figures 26 and 27) 
Macrophage cells have surface protein receptors that signal complicated pathways 
to enable the transcription of pro-inflammatory cytokines. As mentioned previously, cell 
membranes derived from hypotonic lysing can preserve those membrane receptors and 
therefore allow us to coat those receptors onto nanoparticles. Macrophage membranes 
coated nanoparticles have already been reported to neutralize endotoxin and cytokines both 
in vitro and in vivo. 
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Additionally, the system’s principle to retain nanoparticles is through interacting 
the positively charged poly-L-lysine in fibers with negatively charged cell membrane 
proteins on the coated nanoparticles. Meanwhile, most cytokines are also negatively 
charged, just as the membrane receptors. It is reasonable to predict that similar interactions 
can exist between poly-L-lysine and cytokines. Fibers should also be able to neutralize the 
cytokines as well.  
To verify the hypothesis, two types of cytokines, TNF-α and IL-6, were incubated 
with triplicated samples of 1 mg particle attached nanofibers and results were compared 
with incubation with blank control (no treatment) and 1 mg bare nanofibers. Samples were 
tested for cytokine concentration before incubation with ELISA. The rest of cytokine was 
incubated with the three groups at 37C for 30 mins. Afterwards, the solution was collected 
and spun down for excess nanoparticles. Concentrations of cytokines in the supernatant 
was quantified again using ELISA. The results were compared to the values before 
treatment. 
As expected, poly-L-lysine fibers are able to reduce cytokine levels in both cases. 
In the case of TNF-α, there was a slight reduction of TNF-α after incubating with bare-
fibers without nanoparticles. The surface charge of poly-lysine attracted about 20% of the 
600 pg/ml TNF-α input. When the system is attached with macrophage nanoparticles, the 
level further reduced to below 200 pg/ml. Clearly, the addition of nanoparticles in the 
sample provided an additional boost of neutralizing cytokines, thanks to the TNFR 
receptors on the nanoparticle surface. Meanwhile, using nanoparticles alone was also able 
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to neutralize similar amount of TNF- α , showing that the effect of poly-L-lysine is 
dominated by the efficacy of the nanoparticles. 
 However, when the system was in contact with IL-6, the results showed that the 
polylysine is able to neutralize the majority of the cytokines and that attaching the 
nanoparticles offered no statistical difference compared to the fiber alone. This means IL-
6 has greater affinity to the positive charge sites than TNF-α possibly due to carrying 
different zeta-potential.  
 The cytokine neutralization experiments showed that the system was able to 
effectively reduce the levels of the cytokines in vitro through both specific receptor binding 
and non-specific electrostatic interactions.  
In vitro anti-inflammatory efficacy of curcumin (Figure 28) 
 The in vitro anti-inflammatory efficacy of curcumin was investigated using J774 
macrophage cells. 1 × 10 cells/well were seeded into a 96-well tissue culture plate and 
cultured overnight. 50 ng/ml of LPS was introduced into each well followed by adding the 
treatment groups: no treatment, free curcumin, curcumin loaded nanofibers, and curcumin 
loaded nanofibers with nanoparticles. The mixtures were incubated for 12 hours. At the 
end of the incubation, the supernatant from each well was taken out and centrifuged to 
remove loose nanoparticles and fiber debris. The inflammatory cytokine IL-6 was 
quantified using ELISA.  
 According to the results, 50 ng/ml of LPS successfully induced inflammatory 
response of the J774 cells, with the cells in LPS group expressing three times as much IL-
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6 levels than the blank control. Free curcumin is known to interfere with the NF-κB 
activation process and inhibit cytokine transcription. Therefore, the cellular inflammation 
was almost completely avoided by free curcumin. The twelve-hour incubation period 
allows the majority of curcumin to be released (see curcumin release profile), hence the 
released curcumin was also able to modulate inflammation through similar process of 
signaling pathway mediation as the free curcumin group. Lastly, due to the effective 
potency of curcumin, the nanoparticles fell short in terms of the efficacy. The hybrid group 
showed no added effect from curcumin nanofiber only group.  
In vivo macrophage recruitment study (Figure 29) 
 The macrophages ability to absorb pro-inflammatory cytokines can reduce the 
inflammation phase of wound healing by reducing local cytokine levels and immune cell 
recruitment.  
To investigate the reduction of macrophage recruitment efficacy of our system, two 
non-adjacent 6-mm-diameter skin wounds were created on the lower back of each C57 BL 
mouse. Formulations were applied directly onto the wounds. After 5 days, the wound and 
surrounding tissue were collected and stained with anti-mouse CD68 then with Dylight 649 
anti-mouse IgG secondary antibody then mounted with DAPI.  
According to our results, the retained NPs in the NFs were able to reduce 
macrophage recruitment by almost half due to their cytokine neutralization properties. 
Drug loaded nanofibers provided an even greater amount of macrophage recruitment 
reduction by directly interacting with the NF-κB activation process and many other wound 
healing related processes discussed in the previous sections.  
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Figure 15 fluorescent images of the hybrid system. Top left: curcumin in fiber (GFP). 
Top right: Attached nanofibers (DiD, CY5). Bottom: merged. 
 
 
Figure 16 SEM image of the electrospun PCL nanofibers 
  
63 
 
 
 
 
 
Figure 17 nanofiber diameter distribution  
 
Figure 18 polylysine loading on fiber morphology 
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Figure 19 polylysine (PLL) loading on nanoparticle loading 
 
Figure 20 nanoparticle retention in 72 hours.  
 
Figure 21 curcumin release at 25 C and 37 C in 48 hours 
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Figure 22 ciprofloxacin release in 36 hours 
 
 
 
 
 
Figure 23 Human foreskin fibroblast (HFF) cell proliferation of nanofibers. Left: 
confocal images of proliferated cells. Right: cell count during 72 hours.  
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Figure 24 In vitro bacteria inhibition efficacy of ciprofloxacin loaded nanofibers against 
E. Coli. 
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Figure 25  In vitro biofilm inhibition efficacy of ciprofloxacin loaded nanofibers against 
E. Coli 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 In vitro TNF- neutralization with MNP loaded Nanofibers 
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Figure 27  In vitro IL-6 neutralization with MNP loaded Nanofibers  
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Figure 28 In vitro anti-inflammatory efficacies of Curcumin on J774 macrophage cells 
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Figure 29 In vivo macrophage recruitment reduction of fiber retained MNP and 
curcumin loaded nanofibers. 
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Conclusion: 
 
Nanofibers became the area of intense research after their appealing properties were 
discovered. High surface area and porosity allows biocompatibility and make them an 
excellent platform for drug delivery. Its structure mimics the natural extracellular matrix 
during wound closure. Their highly customizable surface can be tailored to fit various 
needs. Because of their unique physical properties, their drug delivery applications and 
wound healing efficacies have been well-documented in literature. The project was 
designed to take advantage of those fascinating properties of the nanofibers and explore 
the possibility of combining the polymeric fibers with the newly arose cell membrane 
coating technology, while at the same time, use them as a traditional drug delivery medium. 
By incorporating three different components into the polymeric fiber matrix, we built a 
biomimetic hybrid system that modulates inflammation in three major aspects: using 
macrophage membrane coated nanoparticles to neutralize pro-inflammatory cytokine 
secretion to reduce unwanted immune cell recruitment; releasing anti-inflammatory drug, 
curcumin, to reduce the production of cytokines through interfering with the activation of 
NF- κ B; and inhibiting the growth of gram-negative bacteria to further reduce the 
production of endotoxin, which is responsible for inducing chronic inflammation in vivo. 
The three features of the hybrid system were successfully demonstrated in the project. 
Since the system is designed to reduce inflammation and promote surface cell proliferation, 
it can be used as a powerful treatment for wound healing. However, due to the complex 
nature of in vivo cutaneous wound healing, such in vivo experiment was not pursued. 
Further investigation will be conducted to observe the wound healing in mouse model.  
